Tue 1 Dec 2009 | 2:28 EST
You are here: Home > Business & Finance > Stocks > Officers and Directors
Home
Business & Finance
Markets
Deals
Small Business
Green Business
Industries
Industry Summits
Stocks
Advanced Stock Search
Overview
Option Quote
Chart
Officers and Directors
Key Developments
Company News
Press Releases
Financial Highlights
Ratios
Financial Statements
Performance
Insider Trading
Institutional Holders
Estimates
Recommendations
Analyst Research
Funds
ETFs
Currencies
Commodities
Options
Economy
Bonds
Analyst Research
Portfolio
News
Do More With Reuters
RSSRSS Feed
Widgets
Mobile
Podcasts
Newsletters
Your View
Partner Services
CareerBuilder
Affiliate Network
Professional Products
Support (Customer Zone)
Reuters Media
Financial Products
About Thomson Reuters

Officers and Directors For Impax Laboratories, Inc.

Impax Laboratories, Inc. (IPXL.O) (Consolidated Issue listed on NASDAQ Global Market)
sector: Healthcare . industry: Pharmaceuticals - Generic & Specialty ยท View IPXL on other exchanges
As of  30 Nov 2009
11.40USD
Price Change
+0.05
Percent Change
+0.44%
 
Research Another Stock: Symbol Look-up

Name Age Since Current Position
Hildenbrand, Charles 57 2004 Senior Vice President - Operations
Mengler, Christopher 46 2009 President, Global Pharmaceuticals Division
Hsu, Larry 60 2006 President, Chief Executive Officer, Director
Nestor, Michael 56 2008 President - Impax Pharmaceutical Division
Markbreiter, Michael 47 1997 Director
Oh, Kim Sun 61 1999 Director
Fleming, Nigel 54 1999 Director
Benet, Leslie 71 2001 Director
Terreri, Peter 51 2003 Director
Koch, Arthur 55 2005 Chief Financial Officer, Senior Vice President - Finance
Burr, Robert 58 -- Chairman of the Board